Name: Violations Of 21 CFR Part 312 - Investigational New Drug Application: Warning Letters Issued by U.S. Food and Drug Administration
Price: 142.80 EUR
Availability: InStock
Author: Chang, C.
ISBN: 9781514626634

portada Violations Of 21 CFR Part 312 - Investigational New Drug Application: Warning Letters Issued by U.S. Food and Drug Administration

Violations Of 21 CFR Part 312 - Investigational New Drug Application: Warning Letters Issued by U.S. Food and Drug Administration

Type

Physical Book

Author

C. Chang

Publisher

Createspace

Language

English

Pages

426

Format

Paperback

Dimensions

28.0 x 21.6 x 2.2 cm

Weight

0.98 kg.

ISBN13

9781514626634

Synopsis "Violations Of 21 CFR Part 312 - Investigational New Drug Application: Warning Letters Issued by U.S. Food and Drug Administration"

Inspection teams often know that a deficiency at one company will often be found at others, so they tend to look for what teams have found in previous inspections. A numerical analysis of past inspections results in the discovery of inspection trends for future inspections. This analysis contains a collection of violations listed in the Warning Letters (WLs) issued by U.S. Food and Drug Administration (FDA) that are available to the public on FDA website, www.fda.gov, as of May 23, 2015. Specifically, the violations included in this analysis are extracted from Warning Letters issued since January 2005. The violations collected here are specifically for failures to meet the requirements described in U.S. Code of Federal Regulations (CFR) Title 21 Food and Drugs, Part 312 Investigational New Drug Application. As of May 23, 2015, there were 121 warning letters issued describing violations of Code of Federal Regulations Title 21 - Food and Drugs Part 312 Investigational New Drug Application. Within these warning letters, 382 violations are listed in this book. The analysis also includes summary of FDA Inspectional Observation issued on Form 483.

Customers reviews

Have you read this book? Login to add your review.

More customer reviews

0% (0)
0% (0)
0% (0)
0% (0)
0% (0)

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews

Violations Of 21 CFR Part 312 - Investigational New Drug Application: Warning Letters Issued by U.S. Food and Drug Administration - Chang, C.

Synopsis "Violations Of 21 CFR Part 312 - Investigational New Drug Application: Warning Letters Issued by U.S. Food and Drug Administration"

Customers reviews

Frequently Asked Questions about the Book

Is the book original?

In what language is the book written?

What is the format of this book?

Questions and Answers about the Book

Opinions about Bookdelivery